cremophor el has been researched along with Sarcoma 180 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, C; Wu, L; Yin, C | 1 |
| He, Z; Li, S; Liu, H; Wang, Y; Xu, H | 1 |
2 other study(ies) available for cremophor el and Sarcoma 180
| Article | Year |
|---|---|
Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol).
Topics: Animals; Antineoplastic Agents, Phytogenic; Folic Acid; Glycerol; Male; Mice; Nanoparticles; Paclitaxel; Polyethylene Glycols; Polymers; Rats; Rats, Sprague-Dawley; Sarcoma 180; Serum Albumin; Solubility | 2010 |
Effect of intratumoral injection on the biodistribution and therapeutic potential of novel chemophor EL-modified single-walled nanotube loading doxorubicin.
Topics: Absorption; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Doxorubicin; Drug Compounding; Drug Delivery Systems; Female; Glycerol; Hydrophobic and Hydrophilic Interactions; Injections, Intralesional; Mice; Mice, Inbred ICR; Nanotubes, Carbon; Neoplasm Transplantation; Pharmaceutical Vehicles; Sarcoma 180; Solubility; Tissue Distribution; Tumor Burden | 2012 |